ClinicalTrials.gov record
Not yet recruiting Phase 1Phase 2 Interventional

A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated

ClinicalTrials.gov ID: NCT07553429

Public ClinicalTrials.gov record NCT07553429. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 29, 2026, 12:17 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A First-in-human, Open-label (Part 1), Randomized (Part 2), Phase I/IIa Trial to Study Safety and Tolerability of Multiple Rising Intravitreal Doses of BI 3812465 in Patients With Center-involved Diabetic Macular Edema

Study identification

NCT ID
NCT07553429
Recruitment status
Not yet recruiting
Study type
Interventional
Phase
Phase 1, Phase 2
Lead sponsor
Boehringer Ingelheim
Industry
Enrollment
49 participants

Conditions and interventions

Interventions

  • High dose BI 3812465 Biological
  • Low dose BI 3812465 Biological
  • Medium dose BI 3812465 Biological

Biological

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 13, 2026
Primary completion
Mar 22, 2027
Completion
Jul 5, 2027
Last update posted
Apr 27, 2026

2026 – 2027

United States locations

U.S. sites
26
U.S. states
11
U.S. cities
25
Facility City State ZIP Site status
Associated Retina Consultants, Ltd. Phoenix Arizona 85020
Retina Macula Institute of Arizona Scottsdale Arizona 85255
Win Retina Arcadia California 91006
California Retina Consultants-Bakersfield-65523 Bakersfield California 93309
Retina-Vitreous Associates Medical Group Beverly Hills California 90211
Global Research Management Glendale California 91204
Retinal Consultants Medical Group Sacramento California 95825
Bay Area Retina Associates - Walnut Creek Walnut Creek California 94598
Retina Group of New England, PC Waterford Connecticut 06385
Retina Group of Florida - Fort Myers Retina Center Fort Myers Florida 33912
East Florida Eye Institute Stuart Florida 34994
Florida Retina Institute Wildwood Wildwood Florida 34785
Cumberland Valley Retina Consultants Hagerstown Maryland 21740
North Carolina Retina Associates Wake Forest North Carolina 27587
Red River Research Partners, LLC Fargo North Dakota 58103
Verum Research, LLC Eugene Oregon 97401
EyeHealth Northwest Portland Oregon 97225
Tennessee Retina Nashville Tennessee 37203
Austin Clinical Research, LLC Austin Texas 78750
Retina Consultants of Texas-Bellaire-67493 Bellaire Texas 77401
Valley Retina Institute, PA McAllen Texas 78503
Medical Center Ophthalmology Associates San Antonio Texas 78240
Retina Consultants of Texas - San Antonio Medical Center San Antonio Texas 78240
Retina Consultants of Texas-The Woodlands-67575 The Woodlands Texas 77384
Strategic Clinical Research Group Weatherford Texas 76087
Emerson Clinical Research Institute Falls Church Virginia 22042

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07553429, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 27, 2026 · Synced Apr 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07553429 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →